Personal information

Verified email domains

Computational Neuro-Oncology, Digital Neuropathology, Clinical Cancer Genomics, Liquid Biopsy, Genomic Medicine
Switzerland

Biography

Sebastian M. Waszak is a Tenure-Track Assistant Professor of Life Sciences at the École Polytechnique Fédérale de Lausanne and an Associate Adjunct Professor of Neurology at the University of California, San Francisco. He is the Director of the Laboratory of Computational Neuro-Oncology at the Swiss Institute for Experimental Cancer Research. He obtained his PhD in Bioengineering and Biotechnology from the École Polytechnique Fédérale de Lausanne and specialized as a postdoctoral fellow in cancer genomics at the European Molecular Biology Laboratory. His research focuses on biomedical data science for children and young adults with brain tumours. He studies the spatio-temporal evolution of childhood brain tumours and develops computational methods to diagnose and monitor patient responses to therapy. He published 80 papers in basic science and medical journals (h-index 40; >11,000 citations), with first/senior author publications in Science (2013), Cell (2015), The Lancet Oncology (2018), Nature (2020a, 2020b), Clinical Cancer Research (2021), and the Journal of Clinical Oncology (2020, 2023). He contributed and introduced novel entities to the 2021 WHO Classification of CNS Tumors and the 2023 WHO Classification of Genetic Tumor Syndromes. His research resulted in revising clinical practice guidelines and amendments to clinical trial protocols. He is a member of the Pacific Pediatric Neuro-Oncology Consortium, the Pediatric DMG Tumor Board at UCSF, and the DIPG/DMG National Brain Tumor Board.

Activities

Employment (6)

École Polytechnique Fédérale de Lausanne: Lausanne, CH

2023-06 to present | Tenure Track Assistant Professor (School of Life Sciences)
Employment
Source: Self-asserted source
Sebastian M. Waszak

University of California, San Francisco: San Francisco, California, US

2021-10-01 to present | Associate Adjunct Professor (Neurology)
Employment
Source: Self-asserted source
Sebastian M. Waszak

University of Oslo: Oslo, NO

2020-03-15 to present | Group Leader (Centre for Molecular Medicine Norway)
Employment
Source: Self-asserted source
Sebastian M. Waszak

European Molecular Biology Laboratory: Heidelberg, DE

2014-04-01 to 2019-03-31 | Postdoctoral Fellow (Genome Biology Unit)
Employment
Source: Self-asserted source
Sebastian M. Waszak

École Polytechnique Fédérale de Lausanne: Lausanne, CH

2010-10-01 to 2014-03-31 | Predoctoral Fellow (Institute of Bioengineering)
Employment
Source: Self-asserted source
Sebastian M. Waszak

Weizmann Institute of Science: Rehovot, IL

2009 to 2009 | Research Assistant (Department of Molecular Genetics)
Employment
Source: Self-asserted source
Sebastian M. Waszak

Education and qualifications (2)

École Polytechnique Fédérale de Lausanne: Lausanne, VD, CH

2010-10-01 to 2014-06-06 | Ph.D. in Biotechnology & Bioengineering (School of Life Sciences)
Education
Source: Self-asserted source
Sebastian M. Waszak

Hochschule Weihenstephan-Triesdorf: Freising, Bayern, DE

2005-10-01 to 2010-08-01 | Dipl.-Ing. (FH) in Bioinformatics (Department of Bioengineering)
Education
Source: Self-asserted source
Sebastian M. Waszak

Professional activities (4)

Society for Neuro-Oncology: Vancouver, CA

2023 | Top Poster Award
Distinction
Source: Self-asserted source
Sebastian M. Waszak

Children's Brain Tumor Network: Philadelphia, US

2022 | Global Inclusion Award
Distinction
Source: Self-asserted source
Sebastian M. Waszak

Swiss Institute of Bioinformatics: Geneva, CH

2017 | Early Career Award
Distinction
Source: Self-asserted source
Sebastian M. Waszak

École Polytechnique Fédérale de Lausanne: Lausanne, CH

2015 | Special Distinction for Doctoral Thesis
Distinction
Source: Self-asserted source
Sebastian M. Waszak

Works (50 of 79)

Items per page:
Page 1 of 2

Data from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Data S1 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Data S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Figures 1-15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S1 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S10 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S11 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S12 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S13 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S14 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S16 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S3 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S4 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S5 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S6 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S7 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S8 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S9 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025-02-18 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors

2025-02-06 | Preprint
Contributors: Ryan J. Corbett; Rebecca S. Kaufman; Shelly W. McQuaid; Zalman Vaksman; Saksham Phul; Miguel A. Brown; Jennifer L. Mason; Sebastian M. Waszak; Bo Zhang; Chuwei Zhong et al.
Source: check_circle
Crossref

Data from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Data S1 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Data S1 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Data S2 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Data S2 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Figures 1-15 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Supplementary Figures 1-15 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S1 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S1 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S10 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S10 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S11 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S11 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S12 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S12 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S13 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S13 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S14 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S14 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S15 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S15 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S16 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S16 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S2 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S2 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S3 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S3 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S4 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref

Table S4 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

2024-09-16 | Preprint
Contributors: Sriram Venneti; Abed Rahman Kawakibi; Sunjong Ji; Sebastian M. Waszak; Stefan R. Sweha; Mateus Mota; Matthew Pun; Akash Deogharkar; Chan Chung; Rohinton S. Tarapore et al.
Source: check_circle
Crossref
Items per page:
Page 1 of 2